ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,116.17
0.32%
Dow Jones
38,386.09
0.38%
US Dollar vs MXN
16.97595
-0.22%
Brent Oil
87.555
0.31%
Bitcoin
61,716.91
-3.32%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Arrowhead Pharmaceuticals Inc (ARWR)

  7. Arrowhead Pharmaceuticals Inc (ARWR) Noticias

ARWR Arrowhead Pharmaceuticals Inc

23.13
0.00 (0.00%)
Pre Mercado
Última actualización: 03:28:06
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Arrowhead Pharmaceuticals Inc ARWR NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 23.13 03:28:06
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
23.13
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/4/202408:00GLOBETurnstone Biologics Appoints William Waddill to its Board of..
08/3/202416:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202416:30EDGAR2Form 144 - Report of proposed sale of securities
27/2/202416:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/2/202415:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/2/202415:07EDGAR2Form 8-K - Current report
02/2/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:57EDGAR2Form 144 - Report of proposed sale of securities
26/1/202416:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
17/1/202417:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202416:22EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
16/1/202417:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202417:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202417:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202417:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202415:16EDGAR2Form 144 - Report of proposed sale of securities
11/1/202415:48EDGAR2Form 144 - Report of proposed sale of securities
11/1/202415:38EDGAR2Form 144 - Report of proposed sale of securities
11/1/202415:22EDGAR2Form 144 - Report of proposed sale of securities
11/1/202415:05EDGAR2Form 144 - Report of proposed sale of securities
08/1/202416:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202416:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202416:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202419:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202418:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202416:33EDGAR2Form 144 - Report of proposed sale of securities
05/1/202416:14EDGAR2Form 144 - Report of proposed sale of securities
05/1/202415:58EDGAR2Form 144 - Report of proposed sale of securities
05/1/202415:39EDGAR2Form 144 - Report of proposed sale of securities
05/1/202415:21EDGAR2Form 144 - Report of proposed sale of securities
05/1/202415:08EDGAR2Form 144 - Report of proposed sale of securities
04/1/202416:27EDGAR2Form 8-K - Current report
04/1/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/1/202412:49EDGAR2Form 144 - Report of proposed sale of securities
04/1/202412:25EDGAR2Form 144 - Report of proposed sale of securities
04/1/202412:06EDGAR2Form 144 - Report of proposed sale of securities
04/1/202411:24EDGAR2Form 144 - Report of proposed sale of securities
02/1/202415:44EDGAR2Form 144 - Report of proposed sale of securities
22/12/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202315:34EDGAR2Form 144 - Report of proposed sale of securities
19/12/202315:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202314:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202314:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202314:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202314:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202314:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202316:16EDGAR2Form 8-K - Current report
29/11/202315:10EDGAR2Form 8-K - Current report
29/11/202315:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..

Su Consulta Reciente

NASDAQ
ARWR
Arrowhead Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados